Vault-13

FRAZIER MANAGEMENT LLC

SEATTLE, WA · CIK 1032165 · 13F filing filed 2021-11-12

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

As an employer

US visa salary filings

Job titleFilingsMedianRange
Associate, Investment AnalystSeattle, WA 1 $125,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Frazier Management LLC.

$1.2bn reported value +15.3% vs Q2 2021
41positions
67.1%in top 10
8 new 10 added 5 reduced 1 sold out vs Q2 2021

Holdings, Q3 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 8,434,232 $201.5m16.12% 16.12% UnchangedShares held: Q4 2020 10.5m, Q1 2021 10.5m, Q2 2021 8.4m, Q3 2021 8.4m
2 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 5,827,415 $187.1m14.97% 14.97% UnchangedShares held: Q4 2020 5.8m, Q1 2021 5.8m, Q2 2021 5.8m, Q3 2021 5.8m
3 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 3,566,912 $71.1m5.69% 5.69% UnchangedShares held: Q4 2020 3.6m, Q1 2021 3.6m, Q2 2021 3.6m, Q3 2021 3.6m
4 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 2,674,299 $65.9m5.28% 5.28% AddedShares held: Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 2.1m, Q3 2021 2.7m +536.3k +536,300 25.1%
5 IMAGO BIOSCIENCES INC COM COM 2,971,274 $59.5m4.76% 4.76% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 3.0m
6 VAXCYTE INC COM PCVX PCVX 2,309,554 $58.6m4.69% 4.69% UnchangedShares held: Q4 2020 2.3m, Q1 2021 2.3m, Q2 2021 2.3m, Q3 2021 2.3m
7 TRILLIUM THERAPEUTICS INC COM NEW TR TR 3,123,107 $55.0m4.40% 4.40% UnchangedShares held: Q4 2020 3.1m, Q1 2021 3.1m, Q2 2021 3.1m, Q3 2021 3.1m
8 GRITSTONE BIO INC COM GRTS GRTS 4,667,242 $50.4m4.03% 4.03% AddedShares held: Q4 2020 2.1m, Q1 2021 1.0m, Q2 2021 1.0m, Q3 2021 4.7m +3.6m +3,636,364 352.7%
9 PASSAGE BIO INC COM COM 5,009,219 $49.9m3.99% 3.99% UnchangedShares held: Q4 2020 5.0m, Q1 2021 5.0m, Q2 2021 5.0m, Q3 2021 5.0m
10 KRYSTAL BIOTECH INC COM KRYS KRYS 771,250 $40.3m3.22% 3.22% ReducedShares held: Q4 2020 895.0k, Q1 2021 895.0k, Q2 2021 787.9k, Q3 2021 771.2k -16.6k -16,626 -2.1%
11 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,417,157 $30.5m2.44% 2.44% UnchangedShares held: Q4 2020 1.9m, Q1 2021 1.9m, Q2 2021 1.4m, Q3 2021 1.4m
12 IVERIC BIO INC COM OPHT OPHT 1,838,402 $29.9m2.39% 2.39% ReducedShares held: Q4 2020 2.5m, Q1 2021 2.5m, Q2 2021 2.5m, Q3 2021 1.8m -706.1k -706,098 -27.8%
13 SUTRO BIOPHARMA INC COM COM 1,468,663 $27.7m2.22% 2.22% AddedShares held: Q4 2020 1.0m, Q1 2021 1.0m, Q2 2021 1.0m, Q3 2021 1.5m +467.2k +467,242 46.7%
14 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,505,200 $24.8m1.98% 1.98% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 1.5m
15 ANAPTYSBIO INC COM ANAB ANAB 899,700 $24.4m1.95% 1.95% UnchangedShares held: Q4 2020 899.7k, Q1 2021 899.7k, Q2 2021 899.7k, Q3 2021 899.7k
16 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 3,530,657 $23.1m1.85% 1.85% AddedShares held: Q4 2020 0, Q1 2021 0, Q2 2021 2.3m, Q3 2021 3.5m +1.2m +1,246,691 54.6%
17 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,188,135 $22.7m1.82% 1.82% UnchangedShares held: Q4 2020 1.4m, Q1 2021 1.4m, Q2 2021 1.2m, Q3 2021 1.2m
18 TYRA BIOSCIENCES INC COM TYRA TYRA 1,250,000 $22.0m1.76% 1.76% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 1.2m
19 CHINOOK THERAPEUTICS INC COM ADRO ADRO 1,671,918 $21.3m1.71% 1.71% AddedShares held: Q4 2020 0, Q1 2021 0, Q2 2021 1.1m, Q3 2021 1.7m +571.9k +571,918 52.0%
20 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 1,771,844 $18.9m1.51% 1.51% ReducedShares held: Q4 2020 2.6m, Q1 2021 2.6m, Q2 2021 2.6m, Q3 2021 1.8m -799.6k -799,606 -31.1%
21 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 442,880 $18.4m1.47% 1.47% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 442.9k
22 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 851,306 $17.9m1.43% 1.43% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 851.3k
23 SIERRA ONCOLOGY INC COM NEW COM NEW 804,667 $17.6m1.41% 1.41% AddedShares held: Q4 2020 202.8k, Q1 2021 202.8k, Q2 2021 202.8k, Q3 2021 804.7k +601.9k +601,864 296.8%
24 FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 UNIT 12/09/2025 1,501,000 $15.1m1.20% 1.20% UnchangedShares held: Q4 2020 1.5m, Q1 2021 1.5m, Q2 2021 1.5m, Q3 2021 1.5m
25 REPLIMUNE GROUP INC COM REPL REPL 491,998 $14.6m1.17% 1.17% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 492.0k
26 GRACELL BIOTECHNOLOGIES INC SPONSORED ADS SPONSORED ADS 851,638 $11.8m0.95% 0.95% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 851.6k
27 REGENXBIO INC COM RGNX RGNX 235,809 $9.9m0.79% 0.79% ReducedShares held: Q4 2020 342.0k, Q1 2021 352.0k, Q2 2021 352.0k, Q3 2021 235.8k -116.1k -116,145 -33.0%
28 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 951,814 $9.3m0.75% 0.75% AddedShares held: Q4 2020 0, Q1 2021 578.1k, Q2 2021 578.1k, Q3 2021 951.8k +373.7k +373,710 64.6%
29 MOLECULAR TEMPLATES INC COM COM 1,374,047 $9.2m0.74% 0.74% UnchangedShares held: Q4 2020 841.9k, Q1 2021 1.4m, Q2 2021 1.4m, Q3 2021 1.4m
30 ACLARIS THERAPEUTICS INC COM ACRS ACRS 408,329 $7.3m0.59% 0.59% AddedShares held: Q4 2020 0, Q1 2021 696.0k, Q2 2021 370.7k, Q3 2021 408.3k +37.6k +37,596 10.1%
31 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 156,000 $5.2m0.41% 0.41% UnchangedShares held: Q4 2020 153.5k, Q1 2021 156.0k, Q2 2021 156.0k, Q3 2021 156.0k
32 IMMUNOVANT INC COM IMVT IMVT 585,759 $5.1m0.41% 0.41% AddedShares held: Q4 2020 0, Q1 2021 508.0k, Q2 2021 254.0k, Q3 2021 585.8k +331.8k +331,759 130.6%
33 APTINYX INC COM COM 1,883,244 $4.4m0.35% 0.35% UnchangedShares held: Q4 2020 3.2m, Q1 2021 3.2m, Q2 2021 1.9m, Q3 2021 1.9m
34 EPIZYME INC COM EPZM EPZM 739,369 $3.8m0.30% 0.30% UnchangedShares held: Q4 2020 731.4k, Q1 2021 739.4k, Q2 2021 739.4k, Q3 2021 739.4k
35 ALLENA PHARMACEUTICALS COM ALNA ALNA 3,330,373 $3.0m0.24% 0.24% UnchangedShares held: Q4 2020 3.3m, Q1 2021 3.3m, Q2 2021 3.3m, Q3 2021 3.3m
36 ESSA PHARMA INC COM NEW EPI EPI 358,346 $2.9m0.23% 0.23% AddedShares held: Q4 2020 0, Q1 2021 316.6k, Q2 2021 316.6k, Q3 2021 358.3k +41.7k +41,730 13.2%
37 KALVISTA PHARMACEUTICALS INC COM KALV KALV 156,807 $2.7m0.22% 0.22% NewShares held: Q4 2020 0, Q1 2021 0, Q2 2021 0, Q3 2021 156.8k
38 BELLUS HEALTH INC NEW COM NEW BLU BLU 433,247 $2.6m0.21% 0.21% ReducedShares held: Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 1.3m, Q3 2021 433.2k -863.5k -863,496 -66.6%
39 GALERA THERAPEUTICS INC COM COM 241,000 $2.0m0.16% 0.16% UnchangedShares held: Q4 2020 241.0k, Q1 2021 241.0k, Q2 2021 241.0k, Q3 2021 241.0k
40 FREELINE THERAPEUTICS HLDGS SPONSORED ADS SPONSORED ADS 550,000 $1.9m0.15% 0.15% UnchangedShares held: Q4 2020 550.0k, Q1 2021 550.0k, Q2 2021 550.0k, Q3 2021 550.0k
41 NABRIVA THERAPEUTICS PLC SHS SHS 425,650 $507.0k0.04% 0.04% UnchangedShares held: Q4 2020 425.6k, Q1 2021 425.6k, Q2 2021 425.6k, Q3 2021 425.6k

Sold out since Q2 2021

SecurityTickerShares held beforeValue then
TRANSLATE BIO INC 2,082,789 $57.4m2.1m shares